ADVANCED CANCERS
Clinical trials for ADVANCED CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug TQB2922 enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug called TQB2922, given as a shot under the skin, in about 42 people with advanced cancers that have not responded to standard treatments. The main goal is to check the drug's safety and how the body processes it. This is a first step to see …
Matched conditions: ADVANCED CANCERS
Phase: PHASE1 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Magic mushroom therapy targets Opioid-Resistant cancer pain
Symptom relief Recruiting nowThis study tests whether psilocybin (the active ingredient in magic mushrooms) can safely help relieve severe pain that doesn't respond to opioids in people with advanced cancer. Fifteen adults with advanced cancer and persistent pain will receive psilocybin-assisted therapy. The…
Matched conditions: ADVANCED CANCERS
Phase: PHASE2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
Gene mapping could revolutionize cancer care for thousands
Knowledge-focused Recruiting nowThis study aims to understand how reading the full genetic code of a person's cancer can help doctors choose better treatments. Researchers will analyze tumor samples from 5,000 adults with advanced or metastatic cancers that cannot be cured. The goal is to match each cancer's un…
Matched conditions: ADVANCED CANCERS
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC